David joined WI Harper in late 2001 as an associate in the San Francisco office and moved back to China in 2003. He is now the Managing Director and head of the Beijing office, where he oversees all investments, portfolio management and operations in both life sciences and IT in China. Prior to joining WI Harper, he was a senior venture associate with ABN AMRO Capital and was responsible for developing and executing various acquisition strategies for life sciences, information technology, and Internet companies. Before joining ABN AMRO Capital, David worked at Salomon Smith Barney (the investment banking arm of Citicorp), where he was responsible for analyzing, structuring and marketing companies in the Internet, software and semiconductor sectors. He also spent time at UCSF as a research associate and participated in the High Throughput Genotyping Project for multiple sclerosis for the Department of Neurology.
David plays a fundamental role in the growth and transition of WI Harper¡¯s Beijing operations. He actively manages investments in both Fund V & VI and is a critical part in building the current Beijing team, fundraising and institutionalizing WI Harper¡¯s Fund VI. On the deal side, David is responsible for investments in Cardiva, Celestry Designs (Sold to Cadence in 2003 for $105M), Focus Media (NASDAQ: FMCN), iKang Healthcare Services, Panorama, 3G.cn, Verisilicon, etc.
David was born in Shanghai, grew up in the United States and holds a M.S. degree in biotechnology and business from Northwestern University and a B.S. in biology and chemistry from California State University, San Francisco.